Oxalic Acid

Oxalic Acid

SCHEMBL6626814

CON=C(Cl)C1CN2CCC1C2.O=C(O)C(=O)O

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 3/20 0.54
▸ CHRM4 P08173 3/20 0.54
▸ CHRM1 P11229 3/20 0.54
▸ CHRM3 P20309 3/20 0.54
▸ CHRM5 P08912 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL6628862 0.93 CHRM2 (0.52) CHRM2CHRM4CHRM1CHRM3CHRM5
SCHEMBL6627286 0.92 CHRM2 (0.60) CHRM2CHRM4CHRM1CHRM3CHRM5
SCHEMBL12043252 0.92 CHRM2 (0.60) CHRM2CHRM4CHRM1CHRM3CHRM5
Oxalic Acid SCHEMBL7428197 0.85 CHRM1 (0.41) CHRM2CHRM4CHRM1CHRM3
SCHEMBL6625548 0.84 CHRM2 (0.59) CHRM2CHRM4CHRM1CHRM3CHRM5
SCHEMBL12043259 0.84 CHRM2 (0.59) CHRM2CHRM4CHRM1CHRM3CHRM5
Oxalic Acid SCHEMBL7432773 0.82 CHRM2 (0.54) CHRM2CHRM4CHRM1CHRM3CHRM5
Oxalic Acid SCHEMBL7424442 0.82 CHRM2 (0.54) CHRM2CHRM4CHRM1CHRM3CHRM5
Oxalic Acid SCHEMBL7434211 0.81 CHRM2 (0.52) CHRM2CHRM4CHRM1CHRM3CHRM5
Oxalic Acid SCHEMBL7430158 0.79 CHRM2 (0.86) CHRM2CHRM4CHRM1CHRM3CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0392803-B1 Novel compounds BEECHAM GROUP PLC (GB) 2004-06-16 — — EP disclosed
US-RE35593-E THERAPY FOR DERMENTIA BEECHAM GROUP P.L.C. 1997-08-19 — — US disclosed
US-5278170-A Azabicylo oxime compounds BEECHAM GROUP P.L.C. (GB) 1994-01-11 — — US disclosed
EP-0392803-A1 Novel compounds Beecham Group p.l.c. (GB) 1990-10-17 — — EP disclosed
Send feedback